126 related articles for article (PubMed ID: 37925134)
1. Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
Yi Y; Tianxin Y; Zhangchi L; Cui Z; Weiguo W; Bo Y
Eur J Pharmacol; 2023 Dec; 960():176169. PubMed ID: 37925134
[TBL] [Abstract][Full Text] [Related]
2. Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats.
Liu Z; Chen X; Ye T; Wan W; Yu Y; Zhang C; Yang B
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):33-40. PubMed ID: 36332480
[TBL] [Abstract][Full Text] [Related]
3. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
Yamamura A; Nayeem MJ; Sato M
Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
[TBL] [Abstract][Full Text] [Related]
4. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
[TBL] [Abstract][Full Text] [Related]
5. Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension.
Lv Y; Ma P; Wang J; Xu Q; Fan J; Yan L; Ma P; Zhou R
Eur J Pharmacol; 2021 Nov; 910():174311. PubMed ID: 34245749
[TBL] [Abstract][Full Text] [Related]
6. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
[TBL] [Abstract][Full Text] [Related]
7. Pinocembrin attenuates autonomic dysfunction and atrial fibrillation susceptibility via inhibition of the NF-κB/TNF-α pathway in a rat model of myocardial infarction.
Ye T; Zhang C; Wu G; Wan W; Liang J; Liu X; Liu D; Yang B
Int Immunopharmacol; 2019 Dec; 77():105926. PubMed ID: 31704291
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
[TBL] [Abstract][Full Text] [Related]
9. Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension.
Lu YY; Lin FJ; Chen YC; Kao YH; Higa S; Chen SA; Chen YJ
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232308
[TBL] [Abstract][Full Text] [Related]
10. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
Qin T; Kong B; Dai C; Xiao Z; Fang J; Shuai W; Huang H
Bioengineered; 2022 Feb; 13(2):2697-2709. PubMed ID: 35042435
[TBL] [Abstract][Full Text] [Related]
12. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
15. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
[TBL] [Abstract][Full Text] [Related]
16. Pinocembrin ameliorates atrial fibrillation susceptibility in rats with anxiety disorder induced by empty bottle stimulation.
Ran Q; Zhang C; Wan W; Ye T; Zou Y; Liu Z; Yu Y; Zhang J; Shen B; Yang B
Front Pharmacol; 2022; 13():1004888. PubMed ID: 36339600
[No Abstract] [Full Text] [Related]
17. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.
Strauss B; Sassi Y; Bueno-Beti C; Ilkan Z; Raad N; Cacheux M; Bisserier M; Turnbull IC; Kohlbrenner E; Hajjar RJ; Hadri L; Akar FG
J Mol Cell Cardiol; 2019 Feb; 127():20-30. PubMed ID: 30502350
[TBL] [Abstract][Full Text] [Related]
18. Pinocembrin Decreases Atrial Fibrillation Susceptibility in a Rodent Model of Depression.
Ran Q; Chen X; Zhang C; Wan W; Ye T; Sun Y; Zhao X; Shi S; Yang B; Zhao Q
Front Cardiovasc Med; 2022; 9():766477. PubMed ID: 35669473
[TBL] [Abstract][Full Text] [Related]
19. TRPV2 inhibitor tranilast prevents atrial fibrillation in rat models of pulmonary hypertension.
Ye T; Song Z; Zhou Y; Liu Z; Yu Y; Yu F; Chu Y; Shi J; Wang L; Zhang C; Liu X; Yang B; Yang J; Wang X
Cell Calcium; 2024 Jan; 117():102840. PubMed ID: 38160478
[TBL] [Abstract][Full Text] [Related]
20. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
